Advantage Investment Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$10K Sell
150
-300
-67% -$26.4K 0.01% 648
2019
Q2
$39K Buy
450
+300
+200% +$22.9K 0.03% 393
2019
Q1
$12K Buy
+150
New +$8.32K 0.01% 617

Other funds holding GH

Advantage Investment Management's GH Position: Q3 2019 in Review

Advantage Investment Management reduced its Guardant Health (GH) stake by 67% in Q3 2019, selling an estimated $26.4K and leaving 150 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #648.

Advantage Investment Management first reported a position in GH in Q1 2019 and has held it in 3 quarters since. The position peaked at $39K in Q2 2019. 242 funds tracked by Wall St. Rank hold GH as of Q3 2019.

  • Advantage Investment Management held 150 shares of Guardant Health worth $10K as of Q3 2019.
  • Advantage Investment Management sold 300 Guardant Health shares in Q3 2019, an estimated $26.4K.
  • Guardant Health made up 0.01% of Advantage Investment Management's portfolio in Q3 2019, its #648 holding.
  • Advantage Investment Management first reported a position in Guardant Health in Q1 2019 and has held it in 3 quarters since.
  • Advantage Investment Management's Guardant Health position peaked at $39K in Q2 2019.
  • 242 funds tracked by Wall St. Rank held Guardant Health as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.